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ABSTRACT 
Increasing evidence of the association between ribosomal protein (RP) genes with nasopharyngeal carcinoma 
(NPC) have been derived from findings of their differential expression patterns in NPC cell lines. Nevertheless, 
expression data from a comprehensive list of RP gene family members is still lacking. This paper reports the 
assessment of two RP genes, eL13 and eL14, with regards to their expression patterns in several NPC cell lines 
(TW04, TW01, HK1, HONE1 and SUNE-1) relative to a non-malignant control (NP69). A conventional Reverse 
Transcriptase-Polymerase Chain Reaction (RT-PCR) assay was employed. Analysis of eL13 has never been 
explored before this, whereas investigation of eL14 represents an extended study. We found a general over-
expression trend of eL14 in 40% (2 of 5; TW01 and HONE-1) of the NPC cell lines studied, with higher 
upregulated level in only one (TW01) of them. However, this pattern of expression level is not statistically 
significant. Expression of eL13 was not detected in any of the cell lines used. The inconsistency of these expression 
patterns demonstrates an elusive nature of RP activities in the malignancy of the nasopharynx. 
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Nasopharyngeal carcinoma (NPC) is a subset of human head and neck squamous cell cancer with unique endemic 
distribution and etiological factors (Hildesheim & Levine, 1993), and represents a malignancy that arises from the 
surface epithelial lining at the upper part of the throat and behind the nostrils – the nasopharynx (Brennan, 2006). 
NPC is prevalent in Southern China and South East Asia with a higher incidence among the Chinese compared to 
other ethnicities, notably with the Cantonese dialect group (Armstrong, Kutty, Dharmalingam & Ponnudurai 1979; 
Li, Yu & Henderson, 1985). In the East Malaysian state of Sarawak, the Bidayuh community is the highest risk 
group (Devi, Pisani, Tang & Parkin, 2004; Sim, Tiong, Selva, Ong & Teh, 2010a; Tiong & Selva, 2005), with 
family history as a strong predictor (Yeo, Beh, Tan & Pei Jye, 2018). Etiological factors of NPC can include 
Epstein-Barr Virus (EBV) infection, genetic predisposition, dietary and other environmental influences (Chang & 
Adami, 2006). WHO Classification of NPC divides it into 2 major types: Type 1, the keratinizing squamous cell 
carcinoma; and Type 2, non-keratinizing carcinoma. Type 2 is further divided into Type 2a, undifferentiated 
carcinoma; and Type 2b, differentiated carcinoma. Type 2 is the most common and constitutes 95% of NPC cases 
in high-incidence areas (Peterson & Nelson, 2013). Type 1 is rare and more common in non-endemic populations 
(Li & Zong, 2014). Type 2 is associated with positive EBV serology, more radiosensitive, and frequently 
associated with lymph node and distant metastasis (Peterson & Nelson, 2013). A major concern of NPC is that 
63.6% of diagnosed cases are discovered at later stages (Azizah, Saleha, Hashimah, Asmah & Mastulu, 2015). It 
remains one of the most misdiagnosed cancers because early signs and symptoms were often mistaken as common 
illnesses such as nasal congestion, headache and sore throat, hence the urgency for accurate early detection 
biomarkers (Cho, 2007). To facilitate closer biomolecular studies, NPC cell line models have been established 
since 1975 (Gullo, Low & Teoh, 2008). 
 
For over two decades, the functions of ribosomal protein (RP) genes have been linked to activities beyond 
ribosome-mediated protein synthesis (Wool, 1996). These extra-ribosomal roles include apoptosis, cell cycle 
arrest, cell proliferation, cell migration and invasion, and DNA damage repair (Wang et al., 2015; Xu, Xiong 
& Sun, 2016). Their association and involvement with various cancers have been extensively discussed (de las 
Heras-Rubio, Perucho, Paciucci, Vilardell & LLeonart, 2013; Goudarzi & Lindström, 2016; Xu et al., 2016). In 
NPC, association of malignancy with specific RP genes is increasingly evident (Dolezal, Dash & Prochownik, 
2018; Fang et al., 2008; Sim, Toh & Tiong, 2008; Sim, Ang, Ng, Lee & Narayanan, 2010b; Sim, Chan, Ng, Lee 
& Narayanan, 2016; Sim, Ng, Lee & Narayanan, 2017; Sim, Chee, Vasudevan, Ng & Chan, 2018; Yang et al., 





2005). Despite this, the functional significance of putative NPC-associated RP genes remains elusive due to 
inconsistency in their expression patterns among studies (Ma et al., 2012). This highlighted the complexity of 
their mechanism in tumor development and malignant transformation of NPC cells. The two RP genes studied 
herein are eL13 and eL14, both encoding components for the 60S (large) subunit of the ribosome complex. 
eL13 and eL14 are found in chromosomal positions 16q24.3 and 3p21.3, respectively. Correlation between 
upregulation of eL13 and cancers was demonstrated in gastrointestinal cancer (Kobayashi et al., 2006), 
melanoma (Kardos, Dai & Robertson, 2014), colorectal cancer (Takemasa et al., 2012; Xu et al., 2017). 
However, it remains relatively ubiquitous in clear-cell renal carcinoma irrespective of clinico-pathological 
characteristics (Wierzbicki et al., 2014). Expression behavior of eL13 in NPC has not been reported in 
literature. Early evidence of eL14’s involvement in cancers was from observation of loss of heterozygosity 
(LOH) in the loci of eL14 in the lung, oral squamous cell, and renal cell carcinomas (Shriver et al., 1998). 
This was also found in esophageal squamous cell carcinoma (He et al., 2007), and breast cancer (Aarøe et al., 
2010; Huang et al., 2006). Interestingly, decreased expression of the gene was also observed in a majority of 
breast carcinomas (Huang et al., 2006). Findings of similar expression behavior were seen in a Type 2b 
(differentiated non-keratinizing) NPC cell line (Sim et al., 2018). Such observation remains to be identified in 
other types of NPC cells. In this paper we explored the association of eL13 and eL14 with NPC by assessing 
differential expression patterns between NPC and non-malignant nasopharyngeal epithelial cell lines. 
 
MATERIALS & METHODS 
 
Cell Culture 
The NPC cell lines used in this study were HK1 (Huang et al., 1980), HONE1 (Glaser et al., 1989), TW01, 
TW04 (Lin et al., 1993), and SUNE1 (Teng, Ooka, Huang & Zeng, 1996). HONE1, SUNE1, and TW04 were 
from Type 2a NPC, HK1 was from Type 2b, and TW01 was from Type 1. The normal nasopharyngeal 
epithelial cell line, NP69 (Tsao et al., 2002) was the normal control. All NPC cell lines were cultured in RPMI-
1640 media supplemented with 10% foetal calf serum (FCS), 10 U/ml penicillin and 10 µg/ml streptomycin. 
The NP69 cell line was cultured in keratinocyte serum-free media (DKSFM) supplemented with 5% fetal calf 
serum, 100 U/ml penicillin, 100 μg/ml streptomycin. All cells were maintained at 37ºC in a humidified 
atmosphere with 5% CO2.  
 
RNA Extraction and Reverse Transcription  
Total cellular RNA was extracted from the cell cultures using TRIzol Reagent (Invitrogen, USA) according to 
the manufacturer’s protocol. Cells (in each culture flask) were rinsed with cold Phosphate Buffer Saline 
solution and treated with TRIzol reagent to be dislodged and homogenized. The homogenate was then 
transferred to 1.5 ml tube and mixed with chloroform (0.2 ml per 1 ml TRIzol). After incubation for 5 min, 
the mixture was centrifuged (10000 × g for 15 min at 4°C). The upper aqueous layer containing RNA was 
transferred to a new 1.5 ml tube and mixed with isopropanol. Following precipitation, the RNA was pelleted 
via centrifugation, washed with 75% ethanol, air-dried, and dissolved in nuclease-free water. Assessment of 
extracted RNAs included agarose gel electrophoresis (AGE) assay, and the optical density measurement at 
absorbance value of 260 and 280 nm using a UV spectrophotometer (Shimadzu, USA or Ultrospec 1100 pro, 
UK). RNAs of all cell lines were converted to cDNAs. First strand cDNA was prepared using Moloney Murine 
Leukemia Virus Reverse Transcriptase (MMLV-RT; Promega, USA). Basically, 2 μg of RNA was reverse 
transcribed using MMLV in a reaction mixture containing 0.5 μg random primers, 1X reaction buffer, 40 mM 
dNTPs, 25 U Recombinant RNasin® Ribonuclease Inhibitor, and 200 U M-MLV RT. The reaction was 
incubated for 60 min at 37°C, and then at 70°C for 15 min. Synthesized complementary DNAs (cDNAs) were 
checked using AGE assay and kept at -20°C until use. 
 
Polymerase Chain Reaction (PCR)   
For each sample, the final PCR mixture (vol. of 25 µL) contained 1X Green Go Taq® Flexi Buffer, 1 mM 
MgCl2, 0.2 mM dNTP mix, 0.625 U GoTaq® DNA Polymerase, 0.4 µM each of forward and reverse primers, 
and 0.25 µg of template cDNA. The cDNA template used was from five NPC cell lines (HK1, SUNE-1, 
HONE1, TW01, TW04) and one normal human nasopharyngeal cell line (NP 69). Thermal cycling conditions 
were initial denaturation at 95°C for 2 min; 30 cycles where each comprised denaturation at 95°C for 30 sec, 
annealing from 51 to 53.5°C (depending on primer type) for 30 sec, and extension at 72°C for 1 min; and a 
final extension at 72°C for 5 min. The sequences of primer pairs were 5’-CTTTCCGCTCGGCTG TTG-3’ 
(forward) and 5’-GCCTTACGTCTGCGGATC-3’ (reverse) with expected amplicon size of 163 bp for eL13; 
5’-TTCTTCCTTCTCGCCTAACG-3’ (forward) and 5’-CCTCCTAAC TTCAGCCTCAA-3’ (reverse) with 
expected amplicon size of 773 bp for eL14; and 5’-AGATCATCAGAATGCCTC-3’ (forward) and 5’-
TACCAGGACATGAGCTTGAC-3’ (reverse) with expected amplicon size of 511 bp for GAPDH. Duplicates 
were done for each test.  





Data Acquisition and Analysis 
Results of PCR assays were assessed using agarose gel electrophoresis (AGE) method. Band intensity was 
documented and measured using ImageQuant gel documentation system via the TotalLab Quant software. 
Subsequently, observed amplicon bands were gel extracted, purified, and sent to a DNA sequencing service 
provider for the acquisition of sequence data. After sequence verification, expression data (band intensity 
value) of each ribosomal protein gene were normalized by comparative assessment with associated expression 
data of the housekeeping gene, GAPDH.  The derivation of normalized value was based on the formula below. 
 
Statistical analysis of difference between detectable transcript expression was carried out using single factor 
ANOVA test. Significance (if any) of eL14 differential expression among the NPC cell lines (TW01, TW04, and 




Following AGE analysis, bands representing amplicons of RP genes can only be detected for eL14. However, this 
is only observable for samples from TW01, TW04, and HONE-1 in Replicate Test 1; and TW01, and HONE-1 in 
Replicate Test 2 (Figure 1). The consistency of PCR assays for eL14 in both sets of replicates was only relevant 
in TW01 and HONE-1 cell lines. There are no bands detected for eL13 in all the cell lines studied. Bands for 
GAPDH were clearly detected in all cell lines studied. Observed bands for eL14 and GAPDH were gel extracted, 
purified and sent for sequence analysis. The DNA sequences obtained verified that the band within the vicinity of 
750 bp is the bone fide amplicon for eL14 gene. Likewise, sequences for the band in the region of 500 bp verifies 
it to be the GAPDH gene. The validity of these amplicons allowed us to proceed further with extraction of band 
intensity values.  
 
 
Figure 1. AGE analysis results of PCR amplicons for eL13, eL14, and GAPDH expressed transcripts in the 
NPC and normal control cell lines.  
 
 
Raw band intensity values were only extractable for eL14 amplicons in samples from TW01, TW04, and HONE-
1 in Replicate Test 1; and TW01, and HONE-1 in Replicate Test 2 (Table 1). No values can be procured from 
eL13 in all the cell lines studied. The band intensity values for the amplicons of the housekeeping gene, GAPDH 
were extracted from all the cell lines studied. Following the process of data adjustment of eL14 against GAPDH 
values, normalized intensity data was derived for samples from TW01, TW04, and HONE-1 in Replicate Test 1; 





and TW01, and HONE-1 in Replicate Test 2 (Table 1). From the normalized data, average value and standard 
deviation information were obtained also. A bar chart of the normalized data for eL14 expression in all the cell 
lines was plotted (Figure 2). This indicated a general trend of eL14 over-expression in TW01, TW04, and HONE-
1 relative to the normal control cell line, NP69 (Figure 2). Nevertheless, based on assessment of the error bars 




Figure 2. Bar chart of normalized band intensity values for eL14 amplicons in the 5 NPC cell lines 
and one normal cell line studied. The y-axis and x-axis represent band intensity values and type of 
cell lines respectively. Error bars are standard deviation value of the average intensity data. 
 
 
A single factor ANOVA test was carried out on the normalized data for eL14 in samples TW01, TWO4, and HONE-
1, as shown in Table 2. This statistical analysis reveals no significant difference in expression levels among the three 
NPC cell lines (p = 0.397, Table 2). Since eL14 levels in TW04 and HONE-1 are not markedly different from NP69 
(normal control) (Figure 2), and that statistical analysis cannot prove that its level in the three cell lines (TW01, 
TWO4, and HONE-1) is significantly different, it should be deduced that the observed general over-expression 




Our findings cannot demonstrate a clear association of eL14 with NPC tumorigenesis. Firstly, we could not prove 
conclusively that it is significantly differentially expressed in NPC cell lines compared to a normal control, albeit 
the observation of a general over-expression in two of the NPC cell lines. In our previous study (Sim et al., 2018), 
eL14 was shown to be significantly down-regulated in HK1 cell line (Type 2a-NPC) but in this report, this was 
not the case. In fact, its expression was not detected at all in HK1 cells. Strangely, it was also not detected in the 
normal or non-malignant cell line, NP69. Its expression, was however, detected in another Type 2a-NPC cell lines, 
HONE-1. The expression level is not remarkably differential in this cell line. The only markedly different (over-
expression) pattern was observed for TW01. This is the first report that reveals an abundance of eL14 expressed 
transcript in a Type 1 NPC category cell. Nonetheless, it is now necessary to reproduce similar exploration of eL14 
expression in TW01 cells and/or investigate its activity in Type 1 NPC tissues in order to have a more conclusive 
inference.  






Table 1. Raw and normalized intensity values of amplicons observed in the AGE analysis of eL14 in the 5 NPC cell lines and one normal control cell line studied. 
Cell 
lines 
eL14 band intensities value for Replicate 1 eL14 band intensities value for Replicate 2 
Average nomalized Error diff 
Raw GAPDH Average GAPDH Normalized Raw GAPDH Average GAPDH Normalized 
NP69 0 103053 
121756 
0 0 340144 
395599 
0 0 0 
TW01 110367 176572 76104 289902 511475 224224 150164 104737 
TW04 36156 99924 44056 0 328327 0 22028 31152 
HK1 0 147687 0 0 445450 0 0 0 
HONE-1 22147 135855 19849 164653 459855 141637 80743 86118 





Table 2. Single Factor ANOVA test result of eL14 expression data in the three NPC cell lines with observable amplicon bands. 
Summary 
Cell lines No. of replicate Sum Average Variance  
TW01 2 300328.2 150164.1 1.1E+10  
TW04 2 44055.64 22027.82 9.7E+08  
HONE-1 2 161485.9 80742.97 7.42E+09  
ANOVA 
Source of variation SS df MS F p-value F crit 
Between cell lines 1.65E+10 2 8.23E+09 1.27532 0.397345 9.552094 
Within cell lines 1.94E+10 3 6.45E+09    
Total 3.58E+10 5     
 





It is clear that our findings herein further obfuscate a pivotal hypothesis on the unequivocal association of RP 
genes (specifically, eL14) to the context of NPC carcinogenesis. However, this confusing scenario of their 
inconsistent expression behaviors between studies is not unprecedented. In 2008, we found eS26 and eS27 to be 
down-regulated in NPC tissues relative to normal samples (Sim et al., 2008), but only to conclude that these two 
RPs have no association with NPC in a later study (Ma et al., 2012).  Similarly, when we reported the under-
expression of eL27, eL41 and eL43 in NPC cell lines (Sim et al., 2010b), the observation was subsequently refuted 
in a later study by us (Sim et al., 2016), whereby these three RP genes were found to be over-expressed in NPC 
situation instead. Such discrepancy in findings between studies implies the complexity and subtlety of RP’s 
involvement in NPC tumorigenesis and malignancy. As such, functional significance of RPs in NPC 
carcinogenesis remains a potent area for deeper molecular research.  
 
The RP gene, eL13 has never been studied in the context of NPC, and this paper is the first to explore its association 
with the cancer. We found no detectable expression of its transcripts in any of the cell line studied, including the 
normal/non-malignant NP69 cells. To infer its inactiveness in neoplastic cells/tissues may be a premature 
conjecture. In fact, its ubiquitous state of expression in clear-cell renal carcinoma is evident regardless of clinico-
pathological presentation (Wierzbicki et al., 2014). Perhaps, this RP gene is specifically not active in the cells 
from the epithelium of the nasopharynx region, and is also not dysregulated when cells in that region are in a 
neoplastic situation. To suggest that its non-association with nasopharyngeal organogenesis or tumorigenesis 
requires further research, particularly in the interrogation of its expression in NPC tissues.  
 
On overall, our data is limited by some inconsistency, particularly in the result of eL14 in TW04. Therefore, an 
experimental repeat of eL14 expression in this cell line is necessary. In fact, more replicates should be applied for 
all cell lines should this study be carried further. An additional caveat to our work here is the limitation of our 
methodology. Our use of the conventional RT-PCR technique should suggest a cautionary interpretation of our 
results. This technique lacks accuracy as far as measurement of real time gene amplification is concerned. Hence, 
it is only useful for the relative assessment of expression level based on end-point quantification of amplicon 
(Walker, Worst & Vrana, 2003). It also lacks sensitivity in the detection of trace level expressed transcripts. Future 
studies on eL13 and/or eL14 in NPC cells or tissues will have to consider the more accurate and sensitive technique 




Expression at transcript level of ribosomal protein gene, eL14 was detected in three nasopharyngeal carcinoma 
cell lines, namely TW01 (Type 1-NPC), and HONE-1 (Type-2a-NPC). The highest level was observed for TW01 
cell line. However, the expression pattern was not significantly differential among the three cell lines, and not 
distinctly diverse to non-malignant scenarios. Besides this, the expression of the ribosomal protein gene, eL13 was 
not detected in all the cell lines studied. Taken together, our results cannot provide a conclusive finding on any 
evident association between eL13 or eL14 and tumorigenesis or malignancy of the human nasopharynx. Instead, 
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